Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
NEW YORK (Reuters Health) – Both obesity and type 2 diabetes, owing to their harmful effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of the Ocular Oncology Section, Yale University School of Medicine, discusses eye tumors ranging from benign to malignant ophthalmic cancers.…
Jimmy K. Lee, MD, Director of the Cornea and Refractive Surgery Section, Yale Eye Center, discusses dry eye treatment, including lubricant drops, cyclosporin and plugging the drainage tube…
NEW YORK (Reuters Health) – Patients with early (stage I and IIA) colon cancer derive similar benefits from intensive postoperative surveillance as those with late stage IIB and…
NEW YORK (Reuters Health) – Combined positron-emission tomography and computed tomography (PET-CT) improves the staging of non-small cell lung cancer (NSCLC) and also reduces the numbers of total…
NEW YORK (Reuters Health) – High intake of saturated and monounsaturated fat may increase the risk of pancreatic cancer, according to a report in the Journal of the…
NEW YORK (Reuters Health) – New research suggests that for some patients with cancer, especially brain tumors and small-cell-lung cancer, the first manifestation is a psychiatric symptom. The…
NEW YORK (Reuters Health) – New research indicates that with effective chemotherapy, children with acute lymphoblastic leukemia (ALL) do not need to receive prophylactic cranial irradiation. Prophylactic cranial…
NEW YORK (Reuters Health) – In patients with unresectable pancreatic cancer, the combination of gemcitabine and a novel cationic liposomal formulation of paclitaxel called EndoTAG-1 substantially prolongs survival…
NEW YORK (Reuters Health) – In a phase III study of patients with progressive well-differentiated pancreatic islet cell tumors, treatment with the tyrosine kinase inhibitor sunitinib significantly prolonged…
